期刊文献+

癌症分子靶向治疗的研究现状 被引量:17

Molecular-targeted therapy for cancer
在线阅读 下载PDF
导出
摘要 分子靶向治疗作为癌症治疗的新手段,以其低毒副作用和高效率的治疗效果正成为癌症治疗研究的热点。在生物体内有许多可以作为癌症治疗靶点的分子,这些靶点分子位于癌细胞的不同位置:细胞膜、细胞质、细胞核及细胞外基质。本文综述了癌症分子靶向治疗领域的研究现状及药物研发现状,为癌症分子靶向治疗的研究提供参考。 Molecular-targeted therapy is a newly developed approach for cancer therapy. With the advantages of lower side effects and higher performance,this approach has become a critical focus of cancer research. There are various molecules that can be treated as therapeutic targets for cancer. These molecules are located in different compartments of cancer cells,such as the cell membrane,cytoplasm,nucleus,and extracellular matrix. In this review,we mainly discussed the current progress in molecular-targeted therapy for cancers and the development of new drugs in this field.
作者 董兵 朱毅敏
出处 《癌症》 SCIE CAS CSCD 北大核心 2010年第3期370-375,共6页 Chinese Journal of Cancer
基金 国家自然科学基金项目(No.30870683)~~
关键词 癌症 分子靶向 治疗 药物 Cancer molecular targeted therapy drugs
  • 相关文献

参考文献43

  • 1Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer [J]. J Clin Oncol, 2003,21 (14) :2787-2799.
  • 2Menard S, Casalini P, Campiglio M, et al. Role of HER2/neu in tumor progession and therapy [ J ]. Cell Mol Life Sci, 2004,61 ( 23 ) : 2965 -2978.
  • 3Coiffier B, Haioun C, Ketterer N, et al. Rituximab ( anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase Ⅱ study [ J]. Blood, 1998,92 (6) : 1927- 1932.
  • 4Dane KY, Chan LA, Rice JJ, et al. Isolation of cell specific peptide ligands using fluorescent bacterial display libraries [ J ]. J Immunol Methods, 2006,309(1-2) :120-129.
  • 5Rowinsky EK, Donehower RC. Paclitaxel (taxol) [J]. N Engl J Med, 1995,332( 15 ) : 1004-1014.
  • 6Wei JC, Xu G, Wu MF, et al. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation [ J ]. Anticancer Res, 2008,28(1A) :327-334.
  • 7Sawyers CL, Hochhaus A, Feldman E, et al. Imatinib induces hematologic and eytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis : results of a phase Ⅱ study [ J ]. Blood, 2002,99 (10) : 3530 -3539.
  • 8Maruyama R, Nishiwaki Y, Tamura T, et al. Phase Ⅲ study, Ⅴ-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small- cell lung cancer [ J ]. J Clin Oncol, 2008,26 (26):4244-4252.
  • 9Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma [J]. N Engl J Med, 2007,356(2) :125-134.
  • 10Koga F, Kihara K, Neckers L. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock Protein 90 [ J]. Anticancer Res, 2009,29 ( 3 ) : 797 - 807.

二级参考文献3

共引文献19

同被引文献114

引证文献17

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部